AMWL · American Well Corp
Market Cap
$202.91M
Shares
17.01M
Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.
Revenue
$249.33M
-2%
FY2025
Net Income
-$95.7M
+54%
FY2025
Operating Margin
-42.22%
+43.3pp
FY2025
Diluted EPS
-$5.96
+57.1%
FY2025
Operating Cash Flow
-$65.95M
+48.2%
FY2025
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | FY2026 (G) | TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|---|---|
| $200M – $205M | $218.53M | $249.33MG | $254.36MG | $259.05MG | $277.19MG | $252.79M | $245.27M | $148.86M | $113.96M | |
| — | $4.23M | $5.17M | $11.77M | $9.31M | $4.96M | — | — | — | — | |
| — | $55.25M | $72.86M | $86.07M | $105.83M | $138.49M | $106.59M | $84.41M | $53.94M | $36.27M | |
| — | $31.76M | $43.27M | $76.27M | $86.46M | $81.63M | $66.15M | $55.1M | $47.67M | $31.63M | |
| — | $75.3M | $88.05M | $121.17M | $126.65M | $146.35M | $94.62M | $166.25M | $54.21M | $37.22M | |
| — | $32.38M | $33.77M | $32.66M | $30.86M | $24.64M | $13.93M | $8.01M | $5.99M | $3.73M | |
| — | $32.55M | $33.96M | $32.97M | $31.51M | $26.17M | $16.09M | $10.15M | $7.76M | $5.33M | |
| — | $9.03M | $11.2M | $20.89M | — | — | — | — | — | — | |
| — | -$81.46M | -$105.27M | -$217.53M | -$692.14M | -$275.85M | -$179.15M | -$227.43M | -$94.7M | -$55.11M | |
| — | — | -42.22% | -85.52% | -267.19% | -99.52% | -70.87% | -92.73% | -63.62% | -48.36% | |
| — | -$48.92M | -$71.31M | -$184.56M | -$660.63M | -$249.69M | -$163.06M | -$217.28M | -$86.94M | -$49.78M | |
| — | -$196K | -$1.7M | -$3.11M | -$2.59M | -$2.28M | -$3.13M | -$2.19M | — | — | |
| — | -$78.25M | -$94.53M | -$209.89M | -$675.31M | -$269.73M | -$179.03M | -$225.8M | -$89.17M | -$52.31M | |
| — | $260K | $434K | $2.75M | $3.86M | $64K | -$5.38M | $639K | -$803K | $0 | |
| — | -$78.46M | -$95.7M | -$208.14M | -$675.16M | -$270.43M | -$176.33M | -$224.43M | -$87.19M | -$52.67M | |
| — | — | -38.38% | -81.83% | -260.63% | -97.56% | -69.76% | -91.51% | -58.57% | -46.22% | |
| — | $1.11M | $733K | -$4.5M | -$4.01M | -$1.64M | -$448K | -$4.19M | -$1.18M | $362K | |
| — | — | — | — | — | -$282.69M | -$183.43M | -$228.58M | -$89.47M | -$50.96M | |
| USD/shares | — | -$4.78 | -$5.96 | -$13.88 | -$47.50 | -$19.72 | -$13.80 | -$45.40 | — | — |
| USD/shares | — | -$4.78 | -$5.96 | -$13.88 | -$47.50 | -$19.72 | -$13.80 | -$45.40 | — | — |
| shares | — | — | 16.05M | 15M | 14.21M | 13.71M | 12.7M | 4.95M | 2.06M | 2.03M |
| shares | — | — | 16.05M | 15M | 14.21M | 13.71M | 12.7M | 4.95M | 2.06M | 2.03M |
Italic rows are computed from reported lines — open a row's info icon for its formula. Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative. (G): the company's own guidance — a (G) column is a guided period not yet reported; a G marker shows how the reported figure landed against the guided range. Non-GAAP-basis guidance (*) is shown as stated and never judged against GAAP actuals.
Price & Valuation
Multiples computed on the strict TTM/EV methodology — today's snapshot against peers, and each ratio recomputed as of past filing dates.
Valuation
EV/Revenue
—
Peer median 1.83×
EV/EBIT
—
Peer median 99.46×
P/E (TTM)
—
Peer median 40.29×
Peer medians compare against the 23 similar-size Health Information Services companies (of 45 listed).
Revenue Breakdown
Annual revenue as the company disaggregates it in its own XBRL filings. Years a component wasn't reported show a dash.
Share mode is each component's slice of the reported components that year — issuers rarely tag every revenue dollar, so slices need not sum to total revenue.
By Product & Service (USD)
| Component | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Platform Subscription | $132,407,000 | $115,543,000 | $112,361,000 | $120,919,000 | $108,254,000 | $98,361,000 | $83,705,000 |
| Visits | $94,286,000 | $116,456,000 | $119,485,000 | $124,350,000 | $116,617,000 | $117,181,000 | $40,701,000 |
| Others | $22,632,000 | $22,365,000 | $27,201,000 | $31,921,000 | $27,918,000 | $29,723,000 | $24,451,000 |
Key facts
CIK
1393584
CUSIP
03044L204
13F (30d)
56 filings
51 filers
Visit website
Investor relations